Cipla is not an American company; it is an Indian multinational pharmaceutical corporation headquartered in Mumbai, India. Although it operates a wholly owned corporate subsidiary known as Cipla USA Inc. to manage its extensive commercial activities, regulatory submissions, and product distributions across the United States, the parent organization is deeply rooted in India. The company leverages its American subsidiary to successfully market FDA-approved generic medications and complex treatments to healthcare providers throughout North America, but its executive board, global headquarters, and primary manufacturing foundations remain based in India.